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Previous experiments inour luboratory suggested that ammonium toxici1y could be medialed by the NMDA 1ype of glutamate receptors. To assess 
this hypothesis we tcstcd if MK-501. a specific antagonist of the NMDA receptor, isable to prevent ammonium toxicity. Mice and ra1s were injected 
i.p. with 12 and 7 mmol/kg of ammonium acetalc. rcspL%tively. 73% of the mice and 70% of the ruts died. However. when the animals were injected 
i.p. with 2 mg/kg of MK-501. I5 min before ammonium injection, only 5% of 1hc mice and 15% of 1hc rats died. The remarkable protection afforded 
by MK-SOi indicates (ha1 ammonia toxici1y is mediated by the NMDA receptor. 
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1. INTRODUCTION 
Ammonia toxicity was first reported in the laboratory 
of Pavlov in 1893 [l]. Injection of large amounts of 
ammonia into animals results in their rapid death. How- 
ever, in spite of much work, the mechanism of ammonia 
toxicity remains elusive. None of the hypotheses ug- 
gested has been fully supported by the experimental 
results. We have studied the effects of hypcrammonemia 
on brain using a new animal model [2,3]. The results 
obtained indicate that ammonia markedly affects gluta- 
matergic neurotransmission and suggest hat ammonia 
toxicity could be mediated by activation of the NMDA 
type of glutamate receptors. To assess this hypothesis, 
we have tested if a highly specific antagonist of the 
NMDA receptor (MK-801) is able to prevent ammonia 
toxicity. It is shown that antagonists of the NMDA 
receptor markedly protect he animals against ammonia 
toxicity. This finding can be of great interest for the 
understanding of the mechanism of acute ammonia tox- 
icity and the possible contribution of hyperammonemia 
to the pathogenesis of hepatic cncephalopathy. 
2. MATERIALS AND METHODS 
Male Swiss albino mice weighing 25-30 g and male Wistar rats 
weighing 250-300 g were used, Mice and rats were injected intrapcri- 
toneally with I2 and 7 mmollkg, respectively, of ammonium acetate. 
To assess if ammonia toxicity is mediated by the NMDA receptor we 
tested the possible protective ffect of 3 an1agonis1s, acting at different 
sites, of this receptor. MK-801 is a potent and selcctivc antagonisl 
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which blocks 1hc ion channel while 2-amino-5.phosphonopentanoic 
acid CAP-5) binds to the glu1amntc binding site. The experimental 
groups were injected i.p. with 2 m&kg of ML801 or 10-500 m&g 
of AP-5 I5 min before injecting ammonium ace~il1e. 
3. RESULTS AND DISCUSSION 
Groups of mice were injected i.p. with 12 mmolikg of 
ammonium acetate. As shown in Table 1, 73% of the 
mice died. However, when the mice were injected i.p. 
with 2 mg/Kg of MK-801 15 min before injection of 
ammonium acetate only 5% died. The same experiment 
was carried out with rats, except hat rats were injected 
with 7 mmol/kg of ammonium acetate. 70% of the rats 
injected with ammonium acetate died compared to only 
15% of those previously injected with MK-801. It 
should be noted that M&801 did not prevent he som- 
nolence, tachypnea nd tonic convulsions produced by 
acute ammonia intoxication. 
These results clearly indicate that MK-801 protects 
the animals from ammonia toxicity. MK-801 is a potent 
and selective antagonist of the NMDA type of gluta- 
mate receptors which bind to the ion channel of the 
receptor complex [4,5]. To further confirm that the pro- 
tective ffect of MK-801 is mediated by its action on the 
NMDA type of glutamate receptors, we assessed the 
effect of another specific antagonist, AP-5, which acts 
on a dif’ferent site (the glutamate binding site) of the 
same receptor. AP-5 also markedly protects mice from 
ammonia toxicity; 80% protection was reached by injec- 
ting 500 mg of AP-S per kg of body weight. As expected, 
iarge amounts of AP-5 VZi2 iieG?Ssa;i~ l . ~od-a L" p.uuLhb n 
protective effect because AP-5 acts at the glutamate 
binding site and must therefore compete with the endo- 
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Protective cffecr. of MK-801 against acute ammonia toxicity 
MK.801 Animals 
injected 
Survivors Survival (%) 
Mice no 41 II 27 
yes 20 19 95 
Rats no 31 10 32 
Yes 31 26 a4 
Mica and rats were injected i.p. with 12 and 7 mmollkg, rcspeciivcly, 
ofammonium acetate. Theexperimental groups were injected i.p. with 
2 mdkg of MK-501 IS min before injecting ammonium acctatc. 
genous glutamate present around the receptor.. Antago- 
nists of other unrelated receptors were ineffective, e.g. 
fiumazenil, an antagonist of the GAl3A-benzodiazepine 
receptor, had no effect at all. 
These results indicate that the toxicity of ammonia is 
mediated by the NMDA type of glutamate receptors. It
has been clearly established that neurotoxicity of gluta- 
mate is mainly due to activation of the NMDA receptor 
which leads to a sustained increase in the intercellular 
level of CA”, which in turn, by mechanisms which are 
beginning to be clarifiell, leads to the death of the cell 
[6]. The same mechanism appears to be involved in 
neuronal damage and death induced by ischemia. 
Under ischemic conditions there is an induction of the 
release of glutamate which would activate the NMDA 
receptor and lead to neuronal damage and death. MK- 
801 also protects neurons from the damage produced by 
ischemia [7,8]. 
We have also found that the release of glutamate in 
brain is greatly increased in hyperammonemic rats. Our 
results suggest hat injection of ammonium acetate in- 
duces a large relaese of glutamate which leads to the 
death of the animal by activation of the NMDA type 
of glutamate receptor. If this receptor is previously 
blocked by an antagonist (MK-801 or AP5) the toxic 
effect of ammonia is prevented. 
Alcohols, by an unknown mechanism, protect mice 
against acute ammonium intoxication. [9]. It has been 
shown recently that alcohols inhibit NMDA-activated 
ion current on neurons [lO,l I]. Moreover, butanol 
which is a more potent inhibitor of the NMDA receptor 
than ethanol [IO] has a greater protective ffect against 
ammonium toxicity [9]. This suggests that the protective 
effect of alcohols could also be mediated by inhibition 
of the NMDA receptor and supports the finding that 
ammonia toxicity is mediated by this receptor. It should 
be noted that MK-801 has previously been used is hu- 
mans as an anticonvulsant for epilepsy patients [12]. 
Therefore, in addition to the basic scientific understand- 
ing, the clinical implications of this work could also be 
of great interest. 
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